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Depressive illness is highly recurrent, frequently
chronic and is associated with a high level of func-
tional disability.1 Large-scale statistical studies have
shown that the number of patients with depres-
sive disorder has increased vastly and depression
combined with anxiety was the most common
reason for admission worldwide in recent years.2–4
Inpatient expenditures for treatment of depression
and other affective disorders ranked in the top
10% of all disorders and first among psychiatric
disorders.5 Studies have reported that significant
variation existed among inpatients’ response to
treatment. Variables reported to be associated with
better treatment response included preadmission
levels of functioning,6,7 additional therapy received
at hospital,6,8 absence of organic brain syndrome,6
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less clinical severity,7 patients’ and psychiatrists’
initial reactions at admission,9 lower medical
burden,8 and shorter hospitalization.6,8
The topic of length of stay (LOS) within inpa-
tient units has become increasingly relevant as
external pressures for economic justification of
each treatment modality included in the cover-
age of National Health Insurance in Taiwan has in-
creased. Studies for trends in acute psychiatric
inpatient care in recent years have shown declines
in both LOS and readmission rate.3 Unlike LOS in
other medical fields, LOS in psychiatry is heavily
influenced by demographic and socioeconomic
characteristics, as well as hospital staffs’ attitudes,10
and is not readily viewed by practitioners as a
meaningful index of clinical performance. Further-
more, extending an unnecessary hospital stay for
a psychiatric patient may actually undermine the
benefits of treatment.10,11 Psychiatrists do not have
a consensus on what is the optimal LOS and effec-
tive treatment for specific diagnoses; nor do we
know the most cost-effective combination of in-
and outpatient treatment for particular types of
patients that might not produce a satisfactory out-
come but can prevent adverse outcomes in a small
minority of patients with complicating psychoso-
cial problems. Studies that examined the factors
influencing LOS within institutions found that
LOS was related to diagnoses,10,12,13 demographic
variables,12 suicidal potential,14 level of psycho-
pathology,10,14 previous psychiatric hospitaliza-
tion,10,15 response to hospitalization,13,16 and
placement considerations.12–14 Given the above-
mentioned interplay between treatment response
and LOS, both need to be assessed if we want to
examine the optimality of inpatient treatment.
Some psychiatric literature discuss individual
inpatient treatment plans and predictors of treat-
ment response and LOS for a mixture of various
psychiatric disorders.6,10,12,17 In the few studies
of depressive inpatients, the data have focused
exclusively on the elderly population and used
outcome assessment via the therapist’s point of
view.8,13,14 A depressed patient usually has a limited
ability to be aware of the general level of severity
of his illness, while the clinician utilizes multiple
cues in addition to a patient’s verbal report to 
facilitate his/her judgment. A low concurrence
between self-rating scales and observer-rating scales
was found during the acute episode of depressive
illness but generally improved at follow-up several
months later when most of the patients recov-
ered.18 Self-report ratings from acutely depressed
patients are not a reliable estimate of the severity
of their symptoms.18 It would be interesting to
determine if the discrepancy of response evalu-
ated by a self-rating scale and an observer-rating
scale exists after acute inpatient treatment and
the value of using a self-rating scale as a reference
for discharge during the acute hospitalization.
This study aimed to examine the variables associ-
ated with treatment response and those with LOS.
We hypothesized that distinct predictors exist for
treatment response evaluated by the observer-rating
scale and the self-rating scale; remission status
defined by the observer-rating measure would 
be more predictable by clinical and demographic
variables than that defined by the self-rating
measure. Furthermore, we hypothesized that pa-
tients with a longer course of hospitalization will
not show significant improvement over those with
shorter LOS.
Methods
Setting
Our psychosomatic ward is located in a university
general hospital and was established in 1992. It
is an open ward with 33 beds. Based on histori-
cal statistical records, the optimal LOS was con-
sidered to be 28 days or fewer, although this was
not strictly followed. The mean number of hos-
pitalization days from a total of 1832 admissions
for a mixture of neurotic disorders from 1992 to
2000 was 27.7 ± 19.7 days.19
Subjects
The study subjects were 67 patients with a cur-
rent episode of DSM-IV major depressive disor-
der (MDD) without psychotic features who were
consecutively admitted to our ward from October
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2000 to June 2001. No patients had episodes of
hypomania or mania.
Measurements
Treatment response was measured using scales
that had been introduced in a previously published
paper regarding the intermediate-term outcome of
the same group of patients.20 They are only briefly
mentioned here.
Two kinds of depressive scales were used in
this study. One is the clinician-rated Hamilton
Rating Scale for Depression (HAM-D-17).21 The
other is the self-rated Beck Depression Inventory
(BDI).22 Remission of depression was defined
objectively as a HAM-D score ≤ 7 or subjectively
as a BDI score ≤ 8.23
The Brief Psychiatric Symptom Rating Scale
(BSRS) was modified from the Derogatis’ Symptom
Checklist-90-R (SCL-90-R)24 and was designed
to be used as a shorter form with 50 items. The
BSRS is a satisfactory global measure and case-
finding self-administered screening instrument
for psychopathology in both psychiatric and non-
psychiatric medical settings. The BSRS was calcu-
lated as a T score based on the mean scores of
non-psychiatric medical inpatients throughout
this study.25 Only the depression and the General
Severity Index (GSI) score are reported in this study.
The Global Assessment of Functioning (GAF)
scale was used to report a clinician’s judgment 
of a patient’s overall level of functioning on a hy-
pothetical continuum of mental health-illness.26
The GAF is an example-anchored scale that pro-
vides a point score from 1 (lowest) to 100 (highest)
describing a patient’s lowest level of functioning.
A GAF score > 80 indicates that patients had no or
minimal symptoms with no more than everyday
problems or concerns.
The Maudsley Personality Inventory (MPI) by
Eysenck measures two aspects of personality char-
acteristics: neuroticism and extroversion.27 The
Chinese version of the MPI has been demonstrated
to have good psychometric properties and time sta-
bility in previous studies conducted in Taiwan.28,29
The Family APGAR index is a family function-
screening questionnaire that measures participants’
perception of five components of family func-
tion: adaptation, partnership, growth, affection,
and resolve.30,31 A higher score indicates a higher
level of family support.
Procedure
For the purpose of assessment of determinants of
treatment response and LOS, data including age
at onset of depression, number of previous hos-
pitalizations, duration of illness before index ad-
mission, family history of affective disorders, the
presence of coexisting disorders, concomitant sui-
cide attempt, and length of hospital stay were
collected prospectively for each patient. The role
of social environment in the etiology and course
of major mental disorders involves two kinds of
measures, i.e. socioeconomic status, referring to
the ordering of persons along a continuum of
economic, political or cultural attributes (income,
educational achievement, occupational prestige)
and social class, referring to social relationships
of ownership and control over productive assets
(owners, self-employed, worker, manager, super-
visor, non-managerial employee).32 Socioeconomic
status is shown for quintile categories, class I to
V, ordered from highest to lowest and based on
education and occupation of key person in their
family.33 Social class defined according to the
Standard Occupational Classification,34 including
nine major groups of occupation, is orderly ranked
into three levels. The first three groups are labeled
as level 1, the middle three groups are labeled as
level 2, and last three groups are labeled as level 3.
During the first week of hospitalization, the
attending psychiatrists rated severity of depression
and functioning level of the hospitalized patients
with the HAM-D and the GAF scale. Patients were
also asked to complete the BDI, BSRS, MPI and
Family APGAR. Three days before discharge, these
assessments were repeated except for the MPI and
Family APGAR.
Statistical analyses
Descriptive statistics were used to calculate basic de-
mographic data. Paired t test was used to compare
the psychometric scores (HAM-D, BDI, depression
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and GSI scores of the BSRS, and GAF) between
admission and discharge. The correlation of base-
line psychometric scores with LOS was calculated
using Pearson’s correlation coefficient. The out-
come variable of remission status at discharge was
defined by HAM-D ≤ 7 and BDI ≤ 8, respectively.
The variable of LOS was also dichotomized into
long LOS and short LOS by a median of 25 days.
All of the sociodemographic and clinical variables
(including psychometric scores) listed in Tables
1 and 2 were examined using univariate logistic
regression to determine if there was any relation-
ship between these variables and outcome variable
or LOS. If a significant bivariate relationship ex-
isted, two stepwise multivariate logistic regression
analyses were performed to find independent pre-
dictors for remission status at discharge or long
LOS. All data were analyzed using SPSS version
11.5 (SPSS Inc., Chicago, IL, USA) for Windows.
Results
Basic and clinical characteristics
The sociodemographic and clinical characteris-
tics of the 67 study subjects are shown in Table 1.
The majority of the patients were women (n = 48,
71.9%), and the mean age of the patients at ad-
mission was 49.2 ± 15.4 years. Thirty-one percent
and 42% of the patients were in the upper (I & II)
and middle (III) socioeconomic status categories
respectively. Most of our patients were in good
physical health and did not have significant cog-
nitive impairment. One third had repeated hospi-
talization due to depressive episode (n=23, 34%).
Nine (13%) patients had first-degree relatives with
affective disorders. Nearly 30% of the patients (n=
19, 28.4%) had made at least one suicide attempt
at the index episode. Mean length of hospital stay
was 25 days (range, 8–55 days).
Treatment response and predictors for
remission status at discharge
The kind and dosage of antidepressants used in
67 patients included imipramine 160 ± 104 mg/
day (n = 5), fluoxetine 31.5 ± 9.9 mg/day (n = 8),
fluvoxamine 158.3 ± 46.3 mg/day (n = 12), parox-
etine 39.5 ± 9.7 mg/day (n = 19), sertraline 100 ±
37.3mg/day (n=19), trazodone 200mg/day (n=2),
venlafaxine 56 mg/day (n = 1), and moclobemide
300 mg/day (n = 1) (mean dosage for all patients
was equivalent to imipramine 178.7 ± 64.7 mg, or
fluoxetine 35.7 ± 12.9 mg/day) during hospital-
ization.35 The scores of scales measuring clinical
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Table 1. Sociodemographic and clinical
characteristics of 67 inpatients with 
major depression
Mean ± SD n (%)
Sociodemographic variables
Age at admission (yr) 49.2 ± 15.4
Age ≥ 65 yr 12 (18)
Sex, female 48 (72)
Married 20 (30)
Education (yr) 10.5 ± 4.8
Socioeconomic status
I & II 21 (31)
III 28 (42)
IV & V 18 (27)
Employment 24 (37)
Living alone 6 (9)
Clinical variables
Age at onset (yr) 44.0 ± 15.1
First episode of 27 (40)
depression
Duration of illness (yr) 5.0 ± 6.4
Duration of current 6.0 ± 8.7
episode (mo)
Comorbid diagnoses
Personality disorder 8 (12)
Medical diagnosis 26 (40)
Previous hospitalization 23 (34)
≥ 1
Suicide attempt at 19 (30)
index episode
Family history of 9 (13)
affective disorder
Length of stay (d) 25.3 ± 10.0
≤ 25 d 35 (52.2)
> 25 d 32 (47.8)
Treatment with ECT 3 (5)
Treatment with 13 (19)
antipsychotics
SD = standard deviation; ECT = electroconvulsive therapy.
severity and remission rates defined in different
criteria are listed in Table 2. All scales showed
significant improvement at discharge compared
with at admission. Almost 80% of all patients re-
sponded to treatment (defined by HAM-D score
< 50% of original score, n = 53). Forty percent
achieved remission objectively (HAM-D ≤ 7, n =
27) and 16% achieved remission subjectively
(BDI ≤ 8, n = 11) at discharge.
Clinical and sociodemographic factors signif-
icantly related to remission status at discharge
(defined by the HAM-D) included sex (p = 0.02),
socioeconomic status (p = 0.006), comorbid with
medical diagnosis (p = 0.02), and severity indexes
(GSI, p = 0.01; BDI, p = 0.04; HAM-D, p = 0.006;
GAF, p = 0.03) by univariate analyses. Two vari-
ables showed borderline significance at p = 0.05
(APGAR and duration of illness). There were no
differences in outcome status at discharge based
on patients’ age, marital status, age at onset of
depression, family history of psychiatric illness,
presence of personality disorder, treatment modal-
ity (combination of electroconvulsive therapy or
antipsychotics), length of hospital stay (either as
interval or categorical variable), and neuroticism
score of the MPI. When all the variables exhibiting
a significant association in the univariate analyses
were included in multivariate logistic regression
analysis, lower socioeconomic status, baseline
GSI, and the HAM-D score remained significantly
associated with remission status defined by the
HAM-D at discharge. The final adjusted model
correctly identified 80.6% of the cases. Meanwhile,
suicide attempt at index episode (p = 0.04), base-
line HAM-D (p = 0.02) and BDI (p = 0.04) were
shown to be significantly related to remission
status defined by the BDI at discharge. Only sui-
cide attempt at index episode showed borderline
significance with subjective remission after adjust-
ing for other variables. The results of multivariate
logistic regression analyses revealed distinct cor-
relates of remission state rated by clinicians or
patients themselves (Table 3). Using social class as
an alternative measure of socioeconomic position
came out the same variables associated with remis-
sion defined by the observer-rating scale (social
class, odds ratio [OR] = 2.67, 95% confidence in-
terval [CI] = 1.20–5.95; baseline GSI, OR = 0.96,
95% CI = 0.94–0.99; HAM-D score, OR = 0.89,
95% CI = 0.81–0.97).
Predictors for LOS
LOS did not show significant correlation with base-
line severity (GSI: γ = 0.13, p = 0.285; HAM-D: γ =
0.02, p = 0.90) or with duration of current episode
of depression (γ = 0.05, p = 0.68). Univariate
Response and length of stay of depressive inpatients
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Table 2. Psychometric scores at admission and discharge
Admission Discharge Remission* at discharge, n (%)
HAM-D† 22.4 ± 7.5 7.7 ± 6.6 27 (40.3)
BDI† 31.9 ± 11.4 20.9 ± 12.4 11 (16.4)
BSRS
Depression† 93.7 ± 21.2 73.7 ± 21.1 10 (14.9)
GSI† 91.0 ± 22.4 72.9 ± 22.6 10 (14.9)
GAF† 45.5 ± 11.1 69.8 ± 12.4 24 (35.7)
Family APGAR 5.7 ± 4.1
MPI
Neuroticism 15.0 ± 4.5
Extroversion 12.0 ± 3.2
*Remission was defined by HAM-D ≤ 7, BDI ≤ 8, depression score of BSRS ≤ 51, GSI of the BSRS ≤ 51 or GAF ≥ 80; †p < 0.001 between
scores at admission and discharge. HAM-D = Hamilton Rating Scale for Depression; BDI = Beck Depression Inventory; BSRS = Brief
Symptom Rating Scale; GSI = General Severity Index; GAF = Global Assessment of Functioning; Family APGAR = Family function in
Adaptation, Partnership, Growth, Affection and Resolve; MPI = Maudsley Personality Inventory.
analyses showed that positive family history of
affective disorders (p = 0.008) and more frequent
hospitalizations (p = 0.03) were significantly as-
sociated with LOS > 25 days. The association of
these two variables still held to predict the prob-
ability of long LOS by stepwise logistic regres-
sion analysis, but with a wide 95% CI. ORs of
previous hospitalization and positive family his-
tory were 2.32 (95% CI, 1.05–5.13) and 12.15
(95% CI, 1.38–106.92), respectively (Table 4).
Discussion
This study, using both objective (HAM-D) and
subjective (BDI) methods of outcome assessment,
found that the predictors for remission defined
by these two assessments were distinct; lower so-
cioeconomic status and less clinical severity at
admission were associated with clinicians’ objec-
tive assessment of remission, while only suicide
attempt during this index episode showed bor-
derline significant association with patients’ sub-
jective assessment of remission. The percentage of
remission status defined by objective assessment
(40%) was greater than that of remission defined
by subjective assessment (15%), and variables
associated with remission defined by clinicians’
judgments were more predictable than those with
remission defined by patients’ subjective eval-
uations. LOS of depressive inpatients was neither
related to baseline severity nor to remission at
discharge. However, patients with positive family
history and more frequent hospitalization were
associated with hospital stay of longer than 
25 days.
Our finding that baseline depression level
was a negative predictor for observer-rated treat-
ment outcome is consistent with another study.7
However, another predictor that more patients
with lower socioeconomic status will be discharged
in a state of remission is counterintuitive, since
low socioeconomic status was a negative predic-
tor of depressive illness in this same group of 
patients at 1-year follow-up20 and in a meta-
analysis.36 This might be explained by clinicians’
concerns regarding the constraint of the resources
of these patients after discharge; therefore, these
patients with lower socioeconomic status tend to
be discharged when they are approaching the
I.C. Cheng, et al
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Table 4. Multiple logistic regression model predicting longer stay of 67 inpatients with major depression
Beta SE p OR 95% CI for OR
Number of hospitalizations* 0.84 0.41 0.04 2.32 1.05–5.13
Positive family history† 2.50 1.11 0.02 12.15 1.38–102.92
*More frequent hospitalization increased the odds of longer stay (> 25 days); †presence of family history increased the odds of longer
stay (> 25 days). SE = standard error; OR = odds ratio; CI = confidence interval.
Table 3. Multiple logistic regression model predicting treatment response to acute inpatient treatment in 67
patients with major depression
Beta SE p OR 95% CI for OR
Remission status defined by HAM-D ≤ 7
Socioeconomic status* 1.33 0.47 0.005 3.77 1.50–9.42
GSI at admission† −0.04 0.03 0.01 0.96 0.93–0.99
HAM-D at admission† −0.13 0.05 0.01 0.88 0.80–0.97
Remission status defined by BDI ≤ 8
Suicide attempt at index episode‡ 1.55 0.79 0.05 4.99 0.29–22.19
*Lower socioeconomic status (SES) increased the odds of being in remission at discharge (1 = upper SES, 2 = middle SES, 3 = lower
SES); †higher scores at admission decreased the odds of being in remission at discharge; ‡presence of suicide attempt at index episode
increased the odds of being in remission at discharge. SE = standard error; OR = odds ratio; CI = confidence interval.
status of being symptom-free. Suicidal potential
is often a contributor to LOS.14 Although suicidal
behaviors are sometimes deemed as manipulative
attempts to gain or prolong admission, hospital
staff fear premature discharge of a suicidal pa-
tient due in part to medicolegal considerations.16
Interestingly, suicide attempt of the index episode
was found to be the only variable associated with
subjective remission at discharge in our study,
which is contradictory to hospital staffs’ antici-
pation of suicide risk mentioned above. Suicide
act is frequently seen in patients with rapid mood
fluctuation. It is speculated that the suicidal pa-
tients consisted of a heterogeneous group, and 
a subgroup of the suicidal patients (31.6%) with
these characteristics rated themselves to be in re-
mission at discharge more than those (10.4%) of
patients without suicide attempt. The above find-
ings demonstrate that clinicians cannot rely solely
on patients’ subjective reports to make decisions
on whether or not to discharge patients.
Consistent with the result of Kirshner’s re-
view,16 treatment outcome of hospitalization did
not show any benefit in those patients with longer
LOS in our study. Neither did LOS predict 1-year
outcome of depressive status after discharge in 
a follow-up study of these patients.20 Factors that
were not measured in this study, such as patients’
readiness to be discharged, various psychosocial
factors influencing disposition and heterogeneous
staffs’ attitudes toward hospitalization, might be
responsible for alternative explanations for LOS
during psychiatric hospitalization. LOS will not
have an association with treatment response unless
the consensual guideline of inpatient treatment
goal is established. Our study results provide pre-
liminary evidence to support that a structured in-
patient treatment plan, e.g. clinical pathway, might
gain some economic benefits without compro-
mising treatment efficacy and outcome of depres-
sive inpatients. Our study showed that patients
with a positive family history tended to stay in
hospital for longer than 25 days. The other vari-
able associated with long LOS was repeated hos-
pitalization, and this finding is consistent with
that of two previous studies.10,15 When the results
of this study and a follow-up study of the same
patient group20 were combined, it was found that
repeated hospitalization was a negative predictor
for both length of hospital stay and 1-year de-
pressive status. Decisions for hospitalizing repeaters
should be considered optimally based on the
balance between treatment efficacy and its impact
on longer hospital stay.
This study had some limitations. First, inpatient
treatment modality was not controlled, and those
placement considerations which might impede
patients’ discharge were not assessed. Second,
some of the important variables were identified
by patients’ report (e.g. family history of affective
illness). However, this information can represent
in part the patient’s concept toward his illness and
is worth being referenced. Third, the relationship
of those variables with treatment outcome was
postulated by a limited case number. The power of
prediction was not large enough to predict point
estimate precisely.
In conclusion, our study found that 80% of
depressive inpatients showed response and 40%
of patients were in a state of remission after hos-
pitalization for 25 days. There was no evidence to
show that patients with long hospital stay would
gain treatment benefits over patients with short
stay. In contrast to remission that was rated ob-
jectively, no variable could be reliably identified
with subjective remission. Psychiatrists should be
aware of the characteristics of patients associated
with long LOS and discuss inpatient treatment
goals with patients to gain early participation 
on admission. Further studies with large sample
size and assessment of pre-admission treatment
history and psychosocial variables related with
placement are needed to examine the effective-
ness of combining in- and outpatient treatment
for patients with major depression.
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